Compare RVMD & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVMD | CVE |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 48.0B |
| IPO Year | 2020 | 2009 |
| Metric | RVMD | CVE |
|---|---|---|
| Price | $193.42 | $32.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 16 |
| Target Price | ★ $259.14 | $36.48 |
| AVG Volume (30 Days) | 2.2M | ★ 6.3M |
| Earning Date | 11-04-2026 | 10-30-2026 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $27.88 |
| Revenue Next Year | $564.95 | N/A |
| P/E Ratio | ★ N/A | $18.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $49.05 | $15.63 |
| 52 Week High | $224.31 | $34.16 |
| Indicator | RVMD | CVE |
|---|---|---|
| Relative Strength Index (RSI) | 44.06 | 57.21 |
| Support Level | $188.18 | $30.35 |
| Resistance Level | $194.19 | $33.78 |
| Average True Range (ATR) | 8.63 | 0.76 |
| MACD | -1.27 | 0.11 |
| Stochastic Oscillator | 41.68 | 80.15 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Cenovus Energy Inc is a Canadian integrated energy group. The group's upstream operations include oil sands projects in northern Alberta; thermal and conventional crude oil, natural gas, and natural gas liquids (NGLs) projects across Western Canada; crude oil production offshore Newfoundland and Labrador; and natural gas and NGLs production offshore China and Indonesia. Its downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. The group's reportable segments are: Oil Sands, Conventional, Offshore, Canadian Refining, U.S Refining, and Corporate and Eliminations. Maximum revenue is generated from its Oil Sands segment. Geographically, the group derives maximum revenue from the U.S., followed by Canada and China.